Marsh & McLennan (MMC) awards options and RSUs to executive Studer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Marsh & McLennan Companies executive Nicholas Mark Studer reported equity awards rather than open‑market trades. He received stock options covering 21,129 shares of Marsh & McLennan common stock at an exercise price of $0.0000 per share. These options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He was also granted 8,044 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. The performance factor for these units was determined on February 24, 2026, and both the options and units convert into Marsh & McLennan common stock on a 1‑for‑1 basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Studer Nicholas Mark
Role
President and CEO of OWG
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 21,129 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 8,044 | $0.00 | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 21,129 shares (Direct);
Restricted Stock Units — 8,044 shares (Direct)
Footnotes (1)
- These options were granted on February 24, 2026 and vest in four equal annual installments on February 24th of 2027, 2028, 2029 and 2030. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis. These restricted stock units relate to performance stock units that were granted on February 23, 2023 for the performance period 2023-2025. The performance factor for these performance stock units was determined on February 24, 2026. Not Applicable
FAQ
What insider transactions did MMC executive Nicholas Mark Studer report on this Form 4?
Nicholas Mark Studer reported equity awards, not market trades. He received stock options on 21,129 shares at an exercise price of $0.0000 and 8,044 restricted stock units, all tied to Marsh & McLennan Companies common stock on a 1‑for‑1 basis.
How many Marsh & McLennan (MMC) stock options were granted to Nicholas Studer?
Nicholas Studer was granted stock options covering 21,129 shares of Marsh & McLennan common stock. These options were granted on February 24, 2026, carry an exercise price of $0.0000 per share, and vest in four equal annual installments from 2027 through 2030.
What is the vesting schedule for Nicholas Studer’s MMC stock options?
The 21,129 stock options granted to Nicholas Studer vest in four equal annual installments. Vesting dates are February 24 of 2027, 2028, 2029 and 2030, aligning the award with multi‑year service and performance at Marsh & McLennan Companies.
What restricted stock units did Nicholas Studer receive from Marsh & McLennan (MMC)?
Nicholas Studer received 8,044 restricted stock units related to performance stock units granted on February 23, 2023 for the 2023–2025 performance period. The performance factor for these units was determined on February 24, 2026, and each unit converts into one share of common stock.
How do Nicholas Studer’s MMC stock options and RSUs convert into common stock?
Both the stock options and restricted stock units awarded to Nicholas Studer convert into Marsh & McLennan Companies common stock on a 1‑for‑1 basis. Each option or unit corresponds to one share, providing a direct link between award value and future share ownership.
Are Nicholas Studer’s MMC Form 4 transactions open‑market purchases or sales?
The Form 4 shows grant or award acquisitions, not open‑market purchases or sales. Transactions coded “A” reflect equity compensation awards—stock options and restricted stock units—granted to Nicholas Studer as part of his role, with no reported market buying or selling activity.